Lupin

LUPIN25 Apr 2024
Pharmaceuticals
+14.85 (+0.94%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Lupin
Lupin
Pharmaceuticals
LUPIN25 Apr 2024
+14.85 (+0.94%)
1D
1M
6M
1Y
5Y
All

Lupin - Share Price & Details

Lowest Today
1580
Highest Today
1600
Today’s Open
1581.3
Prev. Close
1580.05
52 Week High
1703.8
52 Week Low
680.35
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
126.32%
Upper Circuit
Lower Circuit
P/E TTM
35.27
P/B Ratio
3.77
Traded Value(Cr)
0.12
EPS TTM
45.22
Book value
Dividend
0.25%

Price Performance

0.08 %
1 Wk
-1.09 %
1 M
9.69 %
3 M
126.32 %
1 Y
21.50 %
YTD

Traded Volume Movement

Technical Details

Support 3
1561
Support 2
1570
Support 1
1582
Pivot Point :
1592
Resistance 1
1604
Resistance 2
1613
Resistance 3
1626

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Lupin Ltd
₹1,594.90(+14.85/0.94%)
1,594.90+14.8572,687.58126.3235.273.77
Astrazeneca Pharma India Ltd
₹5,333.85(+64.55/1.23%)
5,333.85+64.5513,334.6369.8283.6020.36
Cipla Ltd
₹1,405.40(+6.60/0.47%)
1,405.40+6.60113,471.2954.2934.514.38
Bliss GVS Pharma Ltd
₹116.75(+1.10/0.95%)
116.75+1.101,222.2752.1617.911.25
Abbott India Ltd
₹25,663.50(+201.30/0.79%)
25,663.50+201.3054,534.9415.0747.6017.54
Amrutanjan Health Care Ltd
₹689.65(+9.90/1.46%)
689.65+9.901,993.8214.1645.317.61

About Lupin Ltd

Lupin Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 72687.58 crores. It has reported a sales of Rs. 3999.47 crores and a net profit of Rs. 916.44 crores for the quarter ended December 2018. The company management includes M D Gupta, M D Gupta,Nilesh Deshbandhu Gupta.,Vinita Gupta,R V Satam,Jean-Luc Belingard,Ramesh Swaminathan,Mark D McDade,K B S Anand,Punita Kumar Sinha (Lupin Ltd) among others.
Chairman
M D Gupta
Registered office
Kalpataru Inspire 3rd Floor,Off Western Exp HW Santacruz-E,Mumbai,Maharashtra,400055
FAX :91-22-6640 8131
Background
Incorporation Year1983
Face Value₹2
Market Lot1

Latest News

Tech View: Nifty forms bullish engulfing candle
Nifty on Thursday ended 168 points higher to form a bullish engulfing candle following a series of small candles, suggesting meaningful buying activity during the day. The hourly momentum indicator has triggered a positive crossover which is a buy signal and thus we expect the positive momentum to continue over the next few trading sessions.
25 Apr 2024 | 06:04 PM
Nifty 50 expected to rise 14% to reach 25,810 level by December
Nifty 50 will have scaled up to the 25,810 mark by December 2024, highlighted domestic brokerage Prabhudas Lilladher in its most recent India Strategy Report, Democratic Hat-trick to Re-Rate Markets. The ongoing rule of the NDA government and the La Nina-led regular monsoons, which are predicted to bring policy stability and accelerate demand-driven economic development.
25 Apr 2024 | 05:51 PM
✅Sensex surges 465 points at the close; Nifty near 74,300
✅ Amid positive global cues, benchmark indices closed on a positive note today.
📢 At 3:30 PM, the Sensex improved by 486.50 points or 0.66% at 74,339.74, and the Nifty was up 167.95 points or 0.75% at 22,570.35.
📊Among sectoral, Nifty PSU Bank(⬆️3.77%) turned out to be the best performer while Nifty IT (⬇️0.33%) saw considerable selling.
25 Apr 2024 | 03:35 PM
📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
✅Sensex surges 465 points at the close; Nifty near 74,300
✅ Amid positive global cues, benchmark indices closed on a positive note today.
📢 At 3:30 PM, the Sensex improved by 486.50 points or 0.66% at 74,339.74, and the Nifty was up 167.95 points or 0.75% at 22,570.35.
📊Among sectoral, Nifty PSU Bank(⬆️3.77%) turned out to be the best performer while Nifty IT (⬇️0.33%) saw considerable selling.
25 Apr 2024 | 03:35 PM

How to buy Lupin shares on nse?

To buy Lupin shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Lupin share price today?

The Lupin shares price on nse is Rs.1594.9 today.

What is the market cap of Lupin shares on BSE ?

The company has a market capitalization of Rs.72687.58Cr

What is the PE & PB ratio of Lupin shares ?

PE is 35.27 and PB is 3.77

What is the 52 Week High and Low of Lupin shares?

Lupin stock price high: Rs.1703.8 Lupin stock price low: Rs.680.35

What can be the price of Lupin stocks on BSE?

As of 13:15 hours on 12th May 2023, the stock price of Lupin on the BSE was rupees 773. The price fluctuates constantly throughout trading hours. So, check for the updated price when you invest.

Is it safe to buy Lupin stocks?

Lupin is a leading name in the pharmaceutical sector. It has a market capitalization of rupees 34,804.93 crores with an average trading volume of 61,434.45. The stock might suffer price fluctuations in the short-run depending on market movements. However, the stock price might appreciate and give good returns over the long term. So, it is safe to invest in Lupin if you have a long-term horizon.

What is the current market value per stock of Lupin stocks?

As of 13:15 hours on 12th May 2023, the current market value is rupees 773 on the BSE and rupees 773.10 on the NSE.

Does Lupin have any debts?

Yes, Lupin has debt in its balance sheet. As of 31st March 2023, Lupin had secured loans worth rupees 613.46 crores.

Will Lupin's stock price increase?

While Lupin is trading at rupees 773 on 12th May 2023, its lower circuit is quoted at rupees 688.45, and the upper circuit is at rupees 841.35. Considering the upper circuit, the company’s stock price is expected to increase. Moreover, if you stay invested over a long-term horizon, you can witness a gain in the stock price as the short-term volatilities smoothen out and the company grows.

What is the business plan of Lupin?

Lupin aims to expand its domestic and international business with increased manufacturing of its popular drugs. The company specifically targeted growth in the US and China which would boost its revenue and profitability.